Brief: Aravive Inc Says Current Cash And Cash Equivalents Expected To Fund Operations Into 2022

Aravive

03/08/2020 21:39

Aug 3 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND
PROVIDES RECENT CORPORATE UPDATES
    * CURRENT CASH AND CASH EQUIVALENTS EXPECTED TO FUND
OPERATIONS
INTO 2022
    * ON-TRACK TO INITIATE PHASE 1B/2 TRIAL OF AVB-500 IN CLEAR
CELL
RENAL CELL CARCINOMA IN 2H 2020
    * Q2 LOSS PER SHARE $0.32
    * Q2 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX83dCms 
Further company coverage:  ARAV.O 

 (((Reuters.Briefs@thomsonreuters.com);))